Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Insulin resistance: an adaptive mechanism becomes maladaptive in the current environment - an evolutionary perspective.

Tsatsoulis A, Mantzaris MD, Bellou S, Andrikoula M.

Metabolism. 2013 May;62(5):622-33. doi: 10.1016/j.metabol.2012.11.004. Epub 2012 Dec 20. Review.

PMID:
23260798
2.

From chronic overnutrition to insulin resistance: the role of fat-storing capacity and inflammation.

Lionetti L, Mollica MP, Lombardi A, Cavaliere G, Gifuni G, Barletta A.

Nutr Metab Cardiovasc Dis. 2009 Feb;19(2):146-52. doi: 10.1016/j.numecd.2008.10.010. Epub 2009 Jan 25. Review.

PMID:
19171470
3.

Has natural selection in human populations produced two types of metabolic syndrome (with and without fatty liver)?

Caldwell SH, Ikura Y, Iezzoni JC, Liu Z.

J Gastroenterol Hepatol. 2007 Jun;22 Suppl 1:S11-9. Review. Erratum in: J Gastroenterol Hepatol. 2008 Mar;23(3):501-2.

PMID:
17567458
4.

Diabetes: insulin resistance and derangements in lipid metabolism. Cure through intervention in fat transport and storage.

Raz I, Eldor R, Cernea S, Shafrir E.

Diabetes Metab Res Rev. 2005 Jan-Feb;21(1):3-14. Review.

PMID:
15386813
5.

Muscle insulin resistance: assault by lipids, cytokines and local macrophages.

Kewalramani G, Bilan PJ, Klip A.

Curr Opin Clin Nutr Metab Care. 2010 Jul;13(4):382-90. doi: 10.1097/MCO.0b013e32833aabd9. Review.

PMID:
20495453
7.

Adipose tissue and the insulin resistance syndrome.

Frayn KN.

Proc Nutr Soc. 2001 Aug;60(3):375-80. Review.

PMID:
11681812
8.

Recent advances in the relationship between obesity, inflammation, and insulin resistance.

Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B.

Eur Cytokine Netw. 2006 Mar;17(1):4-12. Review.

10.

Stress augments insulin resistance and prothrombotic state: role of visceral adipose-derived monocyte chemoattractant protein-1.

Uchida Y, Takeshita K, Yamamoto K, Kikuchi R, Nakayama T, Nomura M, Cheng XW, Egashira K, Matsushita T, Nakamura H, Murohara T.

Diabetes. 2012 Jun;61(6):1552-61. doi: 10.2337/db11-0828. Epub 2012 Mar 6.

11.

Getting the message across: mechanisms of physiological cross talk by adipose tissue.

Lee DE, Kehlenbrink S, Lee H, Hawkins M, Yudkin JS.

Am J Physiol Endocrinol Metab. 2009 Jun;296(6):E1210-29. doi: 10.1152/ajpendo.00015.2009. Epub 2009 Mar 3. Review.

12.
13.

Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity.

Heilbronn LK, Campbell LV.

Curr Pharm Des. 2008;14(12):1225-30. Review.

PMID:
18473870
14.

[And what about diabetes?].

Cerasi E.

Bull Acad Natl Med. 2007 Apr-May;191(4-5):941-3; discussion 943. French.

PMID:
18225448
15.

[Insulin resistance and evolution].

Fernández-Real Lemos JM.

Nutr Hosp. 2002 Feb;17 Suppl 1:60-6. Review. Spanish.

PMID:
11928538
16.

Regional differences of insulin action in adipose tissue: insights from in vivo and in vitro studies.

Giorgino F, Laviola L, Eriksson JW.

Acta Physiol Scand. 2005 Jan;183(1):13-30. Review.

PMID:
15654917
17.

Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance.

de Souza CJ, Eckhardt M, Gagen K, Dong M, Chen W, Laurent D, Burkey BF.

Diabetes. 2001 Aug;50(8):1863-71.

18.

Diabetes, lipids, and adipocyte secretagogues.

Faraj M, Lu HL, Cianflone K.

Biochem Cell Biol. 2004 Feb;82(1):170-90. Review.

PMID:
15052336
19.

Skeletal muscle and nuclear hormone receptors: implications for cardiovascular and metabolic disease.

Smith AG, Muscat GE.

Int J Biochem Cell Biol. 2005 Oct;37(10):2047-63. Review.

PMID:
15922648
20.

Molecular mechanisms of human lipodystrophies: from adipocyte lipid droplet to oxidative stress and lipotoxicity.

Vigouroux C, Caron-Debarle M, Le Dour C, Magré J, Capeau J.

Int J Biochem Cell Biol. 2011 Jun;43(6):862-76. doi: 10.1016/j.biocel.2011.03.002. Epub 2011 Mar 8. Review.

PMID:
21392585

Supplemental Content

Support Center